ARMO BioSciences

PharmaceuticalsSeries CRedwood City, USarmobio.com

Latest round

Series C

Last raised

Aug 2017

Total raised

$166M

Investors

14

About ARMO BioSciences

Established in 2012 and based in California, US, ARMO BioSciences Inc. is a biopharmaceutical company that focuses on the development of novel proprietary products that activate the immune systems of cancer patients to recognize and eradicate tumors.

Who invested in ARMO BioSciences

14 investors across 4 rounds

See all investors in ARMO BioSciences

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Aug 29, 2017

    Amount

    $67M

    Investors

    Locked

  2. Series C

    Feb 10, 2016

    Amount

    $50M

    Investors

    Locked

  3. Series B

    May 28, 2014

    Amount

    $30M

    Investors

    Locked

  4. Series A

    Dec 20, 2012

    Amount

    $19M

    Investors

    Locked

Questions about ARMO BioSciences

Who invested in ARMO BioSciences?

ARMO BioSciences has 14 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has ARMO BioSciences raised?

ARMO BioSciences has raised 4 venture rounds. Sign up free to see how much each round raised and the total.

When did ARMO BioSciences last raise money?

ARMO BioSciences's most recent round on record is a Series C, in Aug 2017.

What does ARMO BioSciences do?

Established in 2012 and based in California, US, ARMO BioSciences Inc.

Where is ARMO BioSciences headquartered?

ARMO BioSciences is headquartered in Redwood City, US.

Which VCs invest in companies like ARMO BioSciences?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at ARMO BioSciences's stage. Their profiles are linked below.

Raising like ARMO BioSciences? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.